Provide)nnounces issuance of U.S. Patent for Cardiomyocytes from human embryonic stem – Geron Corporation today announced the issuance of U.S. Patent No. With broad claims to cardiomyocytes from human embryonic stem cells are derived. The patent runs until at least April 2025 . Geron GRNCM1 program developed hESC-derived cardiomyocytes for the treatment of heart disease.

It is not clear, either. ‘ In September 2010, the Food and Drug Administration five e – cigarette distributors cited for ‘unsubstantiated claims and poor manufacturing practices,’according to an agency release. In January 2011 the FDA moved unsuccessfully block e-cigarette imports.. ‘We know nothing about the 95 % of the people who the e-mail is deleted,’said Jennifer Unger, ‘Maybe they are still smoke the same number of cigarettes. Maybe they are even more nicotine than before use because they smoke ordinary cigarettes are and e – cigarettes. With the Institute for Health Promotion and Disease Prevention Research at the University of Southern California, has no connection with both studies. – ‘Neither of these two studies provide scientific evidence that e – cigarettes to end effective in people,’said John Pierce, a professor of cancer prevention at the said Moores Cancer Center at the University of California at San Diego.About EV 3 Inc. – ev3 is a global organization concentrated to medical apparatus onto the catheter – based technology for the endovascular treating vascular disease and disorders. For more info , please visit.